 |
21-25 March 2005 in Brussels, Belgium, 25th International Symposium on Intensive Care and Emergency Medicine (ISICEM) |
 |
|
2-4 February 2005 in New Orleans. Louisiana, USA, 30th International Stroke Conference (ISC) |
|
|
10 - 11 September 2004 in Ingelheim/Mainz, Germany, Leading Stroke Experts Workshop - Advisory Board Meeting |
|
|
23 - 26 June 2004 in Vancouver, Canada, 5th World Stroke Congress (WSC) |
|
|
12 - 15 May 2004 in Mannheim, Germany, 13th European Stroke Conference (ESC) |
|
|
3 - 4 October 2003 in Acapulco, Mexico, Leading Stroke Experts Workshop - Advisory Board Meeting |
|
|
30 August - 3 September 2003 in Vienna, Austria, XXV Annual Congress of the European Society of Cardiology (ESC) |
|
|
30 August - 2 September 2003 in Helsinki, Finland, 7th Congress of the European Federation of Neurological Societies (EFNS) |
|
|
21 - 24 May 2003 in Valencia, Spain, 12th European Stroke Conference (ESC) |
|
|
13 - 15 February 2003 in Phoenix, Arizona, USA, 28th International Stroke Conference (ISC) |
|
|
17 November 2002 in Chicago, Illinois, USA, American Heart Association's Annual Meeting |
|
|
26 - 30 October 2002 in Vienna, Austria, 6th Congress of the European Federation of Neurological Societies (EFNS) |
|
|
4 - 6 October 2002 in Benalmadena, Malaga, Spain, Leading Stroke Experts Workshop - Advisory Board Meeting |
|
|
29 May - 1 June 2002 in Geneva, Switzerland, 11th European Stroke Conference (ESC) |
|
|
21-25 March 2005 in Brussels, Belgium, 25th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
Implementing Stroke Thrombolysis in the Community
This satellite symposium, sponsored by Boehringer Ingelheim and held at the 23rd International Symposium on Intensive Care and Emergency Medicine
(ISICEM) in Brussels on 22nd March 2005, provided some practical
ideas for overcoming the barriers
to increased thrombolysis uptake, and gave an overview of recent acute stroke studies. Professor Werner Hacke (Ruprecht-Karls University, Heidelberg, Germany) chaired the symposium.
Download PDF
2-4 February 2005 in New Orleans. Louisiana, USA, 30th International Stroke Conference (ISC)
Research highlights of 2004
This educational satellite meeting of the International Stroke Conference 2005 held on 3rd February 2005 in New Orleans, Louisiana, provided a valuable review of developments in stroke during 2004. The event was supported by an educational grant from Boehringer Ingelheim. Introducing
the meeting, Chairman Professor Gregory W. Albers (Stanford University
Medical Center, Palo Alto, USA) noted that the faculty would focus on the most clinically relevant research breakthroughs of the year but could not hope to be fully comprehensive.
Download PDF
10 - 11 September 2004 in Ingelheim/Mainz, Germany, Leading Stroke Experts Workshop - Advisory Board Meeting
New Insights - Stroke Management
This year's Leading Stroke Experts Workshop and Advisory Board Meeting hosted by Boehringer Ingelheim once again found international stroke experts exchanging views on developments in their field. Boehringer Ingelheim also benefited from expert input during workshop discussion sessions on topics of special interest to the company particularly relating to their thrombolytic, antithrombotic and blood pressure control products. Professor Philip B. Gorelick, Department of Neurology and Rehabilitation, University of Illinois, Chicago, United States, and Professor Jean-Marc Orgogozo, University Hospital of Bourdeaux, Pessac, France, jointly developed the wideranging scientific programme and chaired the meeting, which was held on 10-11 September 2004 in Ingelheim, Germany, directly at the location of Boehringer Ingelheim head quarter. The programme included two major sessions, the first on acute stroke treatment, and the second on new aspects in secondary prevention, together with a series of workshops for group discussion of a range of related topics.
Download PDF
23 - 26 June 2004 in Vancouver, Canada, 5th World Stroke Congress (WSC)
Addressing opportunities for effective acute stroke care - the right steps for acute stroke therapy and beyond
Interactive Boehringer Ingelheim Satellite Symposium at the 5th World Stroke Congress (WSC) in Vancouver, Canada, 25 June 2004
The steps needed to reach more patients with the benefits of thrombolysis and to distinguish the patients that can gain most from the various secondary prevention options were discussed at this well-supported satellite symposium of the 5th World Stroke Congress held in Vancouver 23-26 June 2004. This interactive satellite symposium, jointly sponsored by Boehringer Ingelheim, Roche and Genentech, was chaired by Professor Kennedy Lees (University of Glasgow, UK) and Professor Hans-Christoph Diener (University of Essen, Germany).
Download PDF
12 - 15 May 2004 in Mannheim, Germany, 13th European Stroke Conference (ESC)
New Directions in Stroke Care - Professional Recommendations for Practical Issues
Interactive Boehringer Ingelheim Satellite Symposium at the 13th European Stroke Conference in Mannheim, Germany, 14th May 2004
The steps to improve a better outcome in acute stroke patients, the properties of antithrombotics in the secondary prevention of stroke, the correlation between cerebrovascular and cardiovascular diseases and the use of international guidelines for the acute treatment and the secondary prevention of stroke were discussed at this well-supported satellite symposium of the 13th European Stroke Conference held in Mannheim 12-15 May 2004. This interactive satellite symposium, jointly sponsored by Boehringer Ingelheim, was chaired by Professor Gary A. Ford (University of Newcastle upon Tyne, UK) and Professor Hans-Christoph Diener (University of Essen, Germany).
Download PDF
3 - 4 October 2003 in Acapulco, Mexico, Leading Stroke Experts Workshop - Advisory Board Meeting
New developments in TIA and stroke care
This year's Leading Stroke Experts Workshop and Advisory Board Meeting hosted by Boehringer Ingelheim once again found international stroke experts exchanging views on developments in their field. Boehringer Ingelheim also benefited from expert input during workshop discussion sessions on topics of special interest to the company particularly relating to their thrombolytic, antithrombotic and blood pressure control products. Professor Gregory Albers of Stanford University Medical Center, Palo Alto, USA, and Professor Werner Hacke of Ruprecht-Karls University, Heidelberg, Germany, jointly developed the wide-ranging scientific programme and chaired the meeting, which was held on 3-4 October 2003 in Acapulco, Mexico. The first of the three major presentation sessions covered acute stroke trials, while two presentation sessions were devoted to aspects of secondary prevention.
Download PDF
30 August - 3 September 2003 in Vienna, Austria, XXV Annual Congress of the European Society of Cardiology (ESC)
Current Controversies In Cardiovascular Protection: Do We Know All There Is To Know?
Boehringer Ingelheim Satellite Symposium at the XXV Annual Congress of the European Society of Cardiology, in Vienna, Austria, 2 September 2003
The European Society of Cardiology plays a major role in the dissemination of knowledge on the prevention and treatment of cardiovascular and stroke diseases. A unique symposium entitled 'Current controversies on cardiovascular protection: do we know all there is to know?' considered evidence for rethinking approaches to the prevention of cardiovascular and stroke morbidity and mortality. The session, which was attended by other 400 delegates, was chaired by two widely acknowledged experts on cardiovascular disease and its consequences. Professor Hans-Christoph Diener from the University of Essen, Germany, is a world expert on stroke, and Professor Salim Yusuf from the Clinical Trials Research Unit based at McMaster University, Hamilton, Canada, is a renowned cardiologist and epidemiologist. The faculty also included two internationally recognised experts on hypertension and its treatment - Professor Peter Sleight and Professor Gordon McInnes. The final member of the faculty was Professor Philip Gorelick, an eminent neurologist from United States with a long-standing interest in the role of drugs in stroke. In recent years, all members of this distinguished faculty have made valuable contributions to groundbreaking outcome studies in cardiovascular and cerebrovascular disease.
Download PDF
30 August - 2 September 2003 in Helsinki, Finland, 7th Congress of the European Federation of Neurological Societies (EFNS)
Modern Stroke Management - Redefining Therapeutic Options From acute treatment to the PRoFESS® trial
Boehringer Ingelheim Satellite Symposium at the 7th Congress of the European Federation of Neurological Societies in Helsinki, Finland, 31st August 2003
Boehringer Ingelheim's satellite meeting discussing developments in the available therapeutic options was a focus of much interest at the 7th Congress of the European Federation of Neurological Societies held in Helsinki in August/September 2003. Five lectures from leading experts gave valuable insights into the available treatments for stroke, amongst which Boehringer Ingelheim products are now prominent. The satellite meeting was chaired by Professor Robert Adams, Medical college of Georgia, Georgia USA and by Professor Markku Kaste, Helsinki University Central Hospital Finland.
Download PDF
21 - 24 May 2003 in Valencia, Spain, 12th European Stroke Conference (ESC)
Modern Stroke Management - Redefining Therapeutic Options: From acute treatment to the PRoFESS® trial
Boehringer Ingelheim Satellite Symposium at the 12th European Stroke Conference in Valencia, Spain, 22 May 2003
Developments in both acute and secondary prevention treatments for stroke that seem likely to reshape future treatment options and provide a brighter outlook for stroke patients were the subject of the Boehringer Ingelheim satellite symposium at the 12th European Stroke Conference 21-24 May 2003 in Valencia, Spain. Presentations at the satellite symposium considered: the implementation of rt-PA (recombinant tissue plasminogen activator, alteplase, Actilyse®) treatment in Europe; some of the questions raised by recent studies of secondary stroke treatments; and the potential of the new PRoFESS® trial to answer those questions. Professor Werner Hacke, Ruprecht-Karls University, Heidelberg, Germany and Professor Gregory Albers, Stanford University Medical Center, Palo Alto, CA, USA chaired the symposium.
Download PDF
13 - 15 February 2003 in Phoenix, Arizona, USA, 28th International Stroke Conference (ISC)
Avoiding Second Strokes - From Platelet Inhibition to the PRoFESS® Trial
Boehringer Ingelheim Satellite Symposium at the 28th ISC International Stroke Conference in Phoenix, Arizona, USA, 13 February 2003
A standing-room-only audience assembled for the satellite symposium organised to announce this largest ever trial in secondary prevention of acute ischaemic stroke. Professor Ralph L. Sacco, Columbia University, New York, and Professor Hans-Christoph Diener, University of Essen, Essen, Germany chaired the satellite symposium. Presentations from other distinguished experts outlined some of the issues that have influenced the planning of this trial.
Download PDF
17 November 2002 in Chicago, Illinois, USA, American Heart Association's Annual Meeting
Anticoagulation and Thrombosis
Lowest bleeding risk in secondary stroke prevention
Meta-analysis of nearly 340,000 patients shows superior safety with dipyridamole/low dose aspirin (AGGRENOX/ ASASANTIN RETARD)
According to a meta-analysis presented at the American Heart Association's Annual Meeting, low dose aspirin (ASA) < 100mg and dipyridamole therapy was associated with the lowest bleeding risk when compared with conventional dose ASA > 100mg, platelet glycoprotein Ilb/Illa inhibitors (abciximab, tirofiban, eptifibatide) and thienopyridines (ticlopidine and clopidogrel). The meta-analysis includes data from 50 clinical trials published from 1988 to 2002, with a total of 338,191 patients, to determine bleeding risks associated with antiplatelet agents.
Download PDF
26 - 30 October 2002 in Vienna, Austria, 6th Congress of the European Federation of Neurological Societies (EFNS)
Modern Stroke Management 2002 and Beyond - Redefining Therapeutic Options
Boehringer Ingelheim Satellite Symposium at the 6th Congress of the European Federation of Neurological Societies in Vienna, Austria, 27 October 2002
Much interest was focused on Boehringer Ingelheim's satellite meeting addressing the current therapeutic options for managing strokes and transient ischaemic attacks (TIAs) at the 6th Congress of the European Federation of Neurological Societies held in Vienna in October 2002. Four lectures from leading experts gave valuable insights into current evidence about the efficacy and safety of the therapeutic options available for stroke, amongst which Boehringer Ingelheim products are prominent. The satellite meeting entitled 'Modern Stroke Management 2002 and Beyond' was chaired by Professor Pierre Fayad, Reynolds Centennial Professor and Chairman of the Department of Neurological Sciences at the University of Nebraska College of Medicine in Omaha, Nebraska, USA and by Professor Franz Aichner, Professor and Chairman of the Department of Neurology at the Wagner-Jauregg Hospital, Linz, Austria.
Download PDF
4 - 6 October 2002 in Benalmadena, Malaga, Spain, Leading Stroke Experts Workshop - Advisory Board Meeting
New Developments in TIA and Stroke Care
High attendance at the Boehringer Ingelheim experts workshop on stroke management reflected the company's strengths in this field.
The International Leading Stroke Experts Workshop hosted by Boehringer Ingelheim gave stroke specialists an excellent opportunity to interact with peers and catch up with recent progress in their field. Benalmadena near Malaga in Spain was the setting for this gathering of around 300 specialists representing 21 countries, which took place on 4-6 October 2002. The scientific programme was jointly developed by Professor Ralph Sacco, Professor of Neurology and Public Health (Epidemiology) at Columbia University College of Physicians and Surgeons, New York and Professor Hans-Christoph Diener, Professor of Neurology at the University of Essen who also jointly chaired the meeting. The programme included two major sessions, the first on antithrombotic therapies, and the second on acute stroke therapy, together with a series of workshops for group discussion of a range of related topics.
Download PDF
29 May - 1 June 2002 in Geneva, Switzerland, 11th European Stroke Conference (ESC)
Modern Stroke Management 2002 and Beyond - Redefining Therapeutic Options
High attendance at the Boehringer Ingelheim Satellite Symposium at the 11th European Stroke Conference in Geneva, Switzerland, 30th May 2002
Strong support for the Boehringer Ingelheim satellite meeting at the 11th European Stroke Conference held in Geneva in May/June 2002 allowed the company to demonstrate its competence in stroke management in the three areas of blood pressure control, thrombolytic therapy and antiplatelet therapy. Most of the large international audience attending the satellite were neurologists or physicians treating stroke and the remainder were nurses treating stroke or staff from pharmaceutical companies. The BI satellite symposium entitled "Modern stroke management - 2002 and beyond" was chaired by Professor Gregory Albers MD, Director Stanford Stroke Center,Stanford University Medical Center Palo Alto, CA, USA and by Professor Julien Bogousslavsky, Professor and Chairman of the Department of Neurology, and Professor of Cerebrovascular Disease, at the University of Lausanne, and Head of the Neurology Service at University Hospital, Lausanne, Switzerland.
Download PDF
|
